Company: HCTI
Filing Date: 2025-11-28
Form Type: S-3
Source: 0001213900-25-115888
Chunk: 2

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-28
Form: S-3
Chunk 2
---
 Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

<div align='center'>HEALTHCARE TRIANGLE, INC.

39,473,684 Shares of Common Stock</div>

This prospectus relates to
the offer and resale by the selling stockholders referenced herein or their assignees (the “Selling Stockholders”) of up to
an aggregate of 39,473,684 shares (the “Conversion Shares”) of common stock, par value $0.00001 per share (“Common Stock”),
of Healthcare Triangle, Inc., a Delaware corporation (the “Company”, “we”, “us” or “our”),
issuable upon the conversion of $15,000,0000 of the Company’s convertible notes (the “Notes”) issued on November 20,
2025 in a private placement transaction (the “Notes Private Placement”) pursuant to a Securities Purchase Agreement dated
November 20, 2025 among the Company and the original Selling Stockholders (the “Securities Purchase Agreement”).

We are filing this registration statement on Form S-3, of which this
prospectus forms a part, to fulfill our contractual obligations to provide for the registration of the resale of the Resale Shares by
Selling Stockholders under the terms of a registration rights agreement dated November 20, 2025 (the “Registration Rights Agreement”)
among the Company and the original Selling Stockholders. See “Notes Private Placement” and “Selling Stockholders”
beginning on pages 14, and 15 of this prospectus for more information about the Notes, and the Selling Stockholders. The registration
of the Conversion Shares does not require the Selling Stockholders to sell any of their shares of our Common Stock.

We are not offering any shares
of Common Stock under this prospectus and will not receive any proceeds from the sale or other disposition of the shares of our Common
Stock covered hereby. See “Use of Proceeds” beginning on page 14 of this prospectus.

The Selling Stockholders identified
in this prospectus, or their pledgees, assignees, donees, transferees or their respective successors-in-interest, from time to time may
offer and sell through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at
privately negotiated prices the shares held by them directly or through underwriters